Clinical assessment of patients with severe coronary artery disease treated with Yiqi Tongluo.

Yang, X Q; Du, C L; Wang, W; Liu, Z; Dong, Y R; Feng, Q M; Yao, L P

Yang, X Q; Du, C L; Wang, W; Liu, Z; Dong, Y R; Feng, Q M; Yao, L P.

Afiliação

Yang XQ; Shanghai municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Du CL; Zhenxin Community Health Service Center, Jiading, Shanghai, China.
Wang W; Shanghai municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Liu Z; Shanghai municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Dong YR; Shanghai municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Feng QM; Shanghai municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yao LP; Department of Cardiothoracic Surgery, Xinhua hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.

J Biol Regul Homeost Agents ; 33(5): 1515-1520, 2019.

Article em En | MEDLINE | ID: mdl-31650821

Assuntos

Doença da Artéria Coronariana/tratamento farmacológico; Medicamentos de Ervas Chinesas/uso terapêutico; Humanos; Medicina Tradicional Chinesa

Palavras-chave

Qi-deficiency and blood-stasis syndrome; Yiqi Tongluo formulation; severe coronary artery disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Medicamentos de Ervas Chinesas Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google